Rare metabolic conditions
- Newborn screening also includes a screen for over 20 additional rare metabolic conditions using mass
spectrometry. - See list of ‘Rare metabolic conditions that are recommended in Australian newborn screening programmes’ that may be included.
- Most of these metabolic conditions follow a pattern of autosomal recessive inheritance.
- In some cases the baby may present in crisis prior to diagnosis by newborn screening.
- Three groups of conditions can be detected: disorders of fatty acid oxidation, organic acidaemias, and
other acidopathies.
Disorders of fatty acid oxidation
- Defects in the ‘burning’ of fatty acids.
- The most common condition is medium chain acyl-coA dehydrogenase (MCAD) deficiency:
- Can be life threatening
- Children with this condition are usually well but may suffer metabolic decompensation if fasting
- May present with lethargy and coma, or hypoglycaemic seizure, during intercurrent illness
- Management consists of avoiding fasting and taking special measures when the child has an
intercurrent infection - Newborn siblings of known cases are at high risk in the first 3 to 4 days of life, and should be monitored and offered 3-hourly feeds
Organic acidaemias/acidurias
- These conditions result from defects in metabolism of, most commonly, amino acids.
- These conditions are rare but can be life threatening.
- Some of these conditions require treatment with a low-protein diet, supplements and medications.
- Early treatment is associated with reduced mortality and morbidity.


